Cite
HARVARD Citation
Le Gouill, S. et al. (n.d.). A NEW BCL‐2 INHIBITOR (S55746/BCL201) AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMA: PRELIMINARY RESULTS OF THE FIRST‐IN‐HUMAN STUDY. Hematological oncology. pp. 47-48. [Online].